Health & Medicine
The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.
Daraxonrasib Doubles Survival in Advanced Pancreatic Cancer, Offering Rare Hope
A new oral drug called daraxonrasib nearly doubled survival time in advanced pancreatic cancer patients, extending median survival from 6.7 to 13.2 months by t…
HighBrazil Gets New Blood Test for Early Alzheimer's Detection
Brazilian laboratory Dasa launches a new blood test for detecting Alzheimer's disease by identifying amyloid plaques, similar to FDA-approved methods, enabling…
HighGLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, heart disease
Pharmaceutical companies are testing GLP-1 medications like Ozempic and Mounjaro for conditions beyond diabetes and weight loss, including Alzheimer's, heart d…
HighWHO endorses precision medicine resolution to bridge global health equity gap
The World Health Assembly endorsed a resolution advancing precision medicine integration into health systems globally, emphasizing equity and addressing dispar…
HighUS doctor with Ebola flown to Germany; family placed in isolation
A US medical missionary contracted Ebola in the Democratic Republic of Congo and was flown to Berlin's Charite hospital for treatment, with his wife and four c…
HighGSK, Vir Secure FDA Emergency Authorization for COVID Antibody Treatment
GSK and Vir Biotechnology received FDA emergency use authorization for sotrovimab, a monoclonal antibody treatment for mild-to-moderate COVID-19 in high-risk a…
HighDual-drug approach targets aggressive osteosarcoma in preclinical study
St. Jude researchers identified a combination therapy targeting EP300 and AKT that slowed osteosarcoma tumor growth in preclinical models, offering the first m…
HighDRC Ebola outbreak spreads amid vaccine shortage and local denial
A deadly Bundibugyo Ebola outbreak in DRC's Ituri province has killed 204 people, with no vaccine or treatment available. Local denial and distrust of authorit…
HighNHS launches record flu drive as experts warn of 60,000 potential deaths this winter
UK health officials warn of potential 60,000 flu deaths this winter as the NHS launches its largest-ever flu vaccination programme, with 35 million people elig…
HighCongo Ebola outbreak surpasses 1,000 deaths with no vaccine or treatment available
A new Ebola strain in Congo has killed over 1,000 people since mid-May, spreading faster than any previous outbreak. No vaccines or treatments exist for this B…
HighEMA recommends XFG-targeted Covid-19 vaccines for 2026-27 season
European Medicines Agency recommends updating Covid-19 vaccines to target the XFG variant for the 2026-2027 season, aligning with FDA guidance to improve prote…
HighNearly 500 Ebola Cases Confirmed in Central Africa as WHO Warns of Pandemic Scale Risk
Nearly 500 confirmed Ebola cases have emerged in Central Africa, with 471 cases and 84 deaths reported across DRC and Uganda. WHO warns the outbreak could riva…
HighNovo Nordisk sues Eli Lilly over 'misleading' weight-loss drug ads
Novo Nordisk is suing Eli Lilly for false advertising, claiming the competitor uses outdated studies comparing higher doses of Novo's GLP-1 drugs to lower dose…
HighOxford researchers identify potential disease-modifying drug for hand osteoarthritis
Oxford researchers identified retinoic acid deficiency in hand osteoarthritis and are testing talarozole, a drug with acceptable safety profile, as a potential…
MediumRare Bundibugyo Ebola variant complicates Congo outbreak response as vaccines remain months away
A Bundibugyo virus outbreak in Congo has killed over 200 people, complicating response efforts due to lack of specific treatments or vaccines for this rare Ebo…
HighML model predicts radiotherapy response in nasopharyngeal cancer patients
Chinese researchers developed an 18-gene machine learning model that predicts which nasopharyngeal carcinoma patients will respond to radiotherapy, potentially…
HighFunctional Medicine Shifts Focus to Patient as Active Participant in Health
Mexican physicians Alexander and Pablo Krouham present a new book advocating functional medicine that addresses root causes of chronic disease and positions pa…
MediumUQ's QED-203 prostate cancer drug advances to human trials with Ellison backing
University of Queensland's QED-203, a novel prostate cancer treatment targeting calcium signalling, moves toward first-in-human trials in 2027 following exclus…
HighDiabetes and ADHD Drugs to Be Tested on Alzheimer's Patients in Multi-Arm UK Trial
A UK trial called AD-SMART will test several drugs at once for Alzheimer's, starting with metformin and atomoxetine, both repurposed from diabetes and ADHD tre…
HighClinical trial explores magnetic brain stimulation as drug-free depression treatment for pregnant women
Researchers are testing transcranial magnetic stimulation combined with therapy to treat depression and anxiety in pregnant people, offering a non-pharmaceutic…
HighExperimental compound shows promise for fat loss without muscle wasting
Researchers have developed an experimental compound that burns fat while preserving muscle mass, potentially offering advantages over existing GLP-1 weight los…
MediumSeven Daily Habits From COVID, Past Outbreaks Prove Critical as Ebola Cases Rise
WHO declares Ebola outbreak in DRC and Uganda a global health emergency. The rare Bundibugyo strain lacks vaccines, making prevention habits from COVID-19 and…
HighSemaglutide shows promise in slowing ageing markers in mice, raising questions for human research
A Nature study found semaglutide, the active ingredient in Ozempic and Wegovy, extended lifespan by 12% in elderly female mice and improved muscle, cognitive a…
HighRadiotherapy Matches Surgery for Prostate Cancer Treatment
A major clinical trial (PACE-A) demonstrates that stereotactic body radiotherapy (SBRT) delivers comparable long-term disease control to surgical prostatectomy…
HighAmerican doctor recovers from Ebola, returns home with family
Dr. Peter Stafford, an American missionary doctor who contracted Ebola in Congo, has returned to the U.S. with his family after recovering from the virus. He a…
HighNovo Nordisk's Wegovy maintains 10% weight loss over four years in long-term trial
Novo Nordisk presented data showing patients maintained approximately 10% weight loss after four years on Wegovy, potentially strengthening reimbursement argum…
HighMachine learning model shows promise for early COVID-19 mortality prediction
Researchers developed an ensemble machine learning model that accurately predicts COVID-19 mortality risk at early infection stages using clinical parameters l…
MediumOzempic's Social Toll: Weight Loss Drug Reshapes Workplace Dynamics and Body Image
GLP-1 medications like Ozempic are reshaping workplace dynamics and raising concerns about mental health effects and body image issues beyond weight loss benef…
MediumResearchers Report High-Dose Psilocybin Trial in Alzheimer's Patient
A medical case report documents an experimental high-dose psilocybin treatment administered to an elderly woman with advanced Alzheimer's disease, raising ques…
MediumCDC urges pregnant women to get COVID vaccine as deaths spike
The CDC issued an urgent alert urging pregnant women to receive COVID-19 vaccines, citing 22 pregnancy deaths in August and data showing 97% of hospitalized pr…
HighEbola Treatment Center Staff Strike Over Unpaid Wages in Congo Outbreak
Healthcare workers at an Ebola treatment center in Congo's Ituri province struck Monday over two months of unpaid salaries, disrupting operations during the co…
HighHistoric pancreatic cancer pill offers new hope for patients
Daraxonrasib, a RAS inhibitor pill, represents a breakthrough treatment for pancreatic cancer patients. The drug is expanding access across major medical cente…
HighCanadian experts warn Ebola outbreak in Congo is 'race against time' with no approved vaccine
A fast-moving Ebola outbreak in central Africa has surpassed 1,000 cases with no approved vaccine or treatment, prompting Canadian experts to warn containment…
HighWHO Chief Races to Contain Rare Ebola Strain in Congo Amid Conflict
WHO chief Tedros Adhanom Ghebreyesus travels to DRC to combat the third-largest Ebola outbreak on record, featuring the rare Bundibugyo strain. Logistical chal…
HighExperimental RAS inhibitor shows promise for NRAS-driven melanoma
Researchers at Huntsman Cancer Institute report that daraxonrasib, a RAS-targeting drug, effectively shrinks NRAS-driven melanoma tumors in preclinical models,…
HighPancreatic cancer pill nearly doubles survival time in breakthrough trial
A breakthrough pancreatic cancer drug demonstrated nearly double survival gains in clinical trials, exceeding expert expectations and potentially transforming…
MediumWHO Declares Ebola Outbreak in Congo and Uganda a Global Health Emergency
The WHO declared an international public health emergency over an Ebola outbreak in DRC and Uganda caused by a rare virus strain with no approved vaccine or tr…
HighReal-time cell observation platform could revolutionize cancer drug discovery
A continuous live-cell observation platform could revolutionize cancer drug discovery and precision medicine by enabling researchers to study cellular behavior…
HighGLP-1 drugs show promise for addiction treatment by dampening reward pathways
GLP-1 receptor agonists, already approved for diabetes and obesity, demonstrate potential in reducing alcohol and drug-seeking behaviors by targeting dopamine…
MediumAustralia's health data push aims to shift care from 'break and fix' to 'predict and prevent'
An opinion piece argues real-world health data, paired with AI, can shift Australian healthcare from reactive treatment toward prediction and prevention, citin…
MediumCongo bans large gatherings as Ebola outbreak escalates; WHO raises risk to 'very high'
Congo banned large gatherings and funeral wakes as Ebola cases surge to 82 confirmed with 750 suspected. WHO upgraded risk to 'very high' for Congo, citing res…
HighGhee on Empty Stomach: Celebrity Trend Without Scientific Backing
Experts debunk claims that consuming ghee on an empty stomach offers special health benefits, cautioning that it's high in saturated fat and calories with limi…
HighMayo Clinic's Precure Research Aims to Catch Disease Before Symptoms Appear
Mayo Clinic launches Precure Research, a multi-disease effort using genetics, environmental exposures, wearables and AI to detect disease before symptoms appea…
MediumSingle-tablet BIC/LEN shows noninferiority to BIC/FTC/TAF in HIV suppression
Phase 3 trial results demonstrate bictegravir/lenacapavir as a noninferior single-tablet alternative to standard three-drug HIV therapy, potentially simplifyin…
HighDela Rosa Tests Negative for COVID-19, Eyes Plasma Donation
Sen. Ronald Dela Rosa tested negative for COVID-19 after a 3-week illness and expressed willingness to donate convalescent plasma containing virus-fighting ant…
HighFDA Approves Novel Cholesterol Drug With Different Mechanism Than Statins
The FDA has approved a new daily cholesterol pill with a different mechanism than statins, potentially offering better outcomes for certain patients. A Columbi…
HighNigerian Experts Push Early Detection to Combat Bone Cancer, Dispel Myths
Orthopaedic oncology specialists in Lagos emphasize early detection and screening as critical to improving bone cancer survival rates, while dispelling myths a…
HighCancer drug shows promise in boosting TB treatment, reducing lung damage
Johns Hopkins researchers found that navitoclax, an experimental cancer drug, significantly enhances standard TB treatments by promoting infected cell death an…
HighGlobal Health Crisis Points: Nipah Deaths, Antibiotic Resistance, Bird Flu Spread
Global health systems face mounting pressures from Nipah virus deaths in India, antibiotic resistance threatening 39M lives by 2050, and emerging mpox cases, o…
HighAustralian advocates push for subsidised GLP-1 drugs to treat PMOS
Australian patient advocates are calling for GLP-1 weight-loss medications to be subsidized through the Pharmaceutical Benefits Scheme for women with PMOS, a c…
High